SET adds new listed securities : CNBIO24's units to be traded on December 9, 2025

The Stock Exchange of Thailand · 2d ago
Listing Listing : Depositary Receipt (DR) DR type : Depositary Receipt Representing Interest from Underlying Foreign Securities DR name : DR ON GLOBAL X CHINA BIOTECH ETF (2820) ISSUED BY FINANSIA SYRUS SECURITIES PUBLIC COMPANY LIMITED DR symbol : CNBIO24 Secondary market : SET Listed date : 09-Dec-2025 Trading date : 09-Dec-2025 Trading Session : Day Trading Session Number of unit (units) : 7,000,000,000 DR : Underlying : 200 : 1 Offering type : Direct listing DR price (baht per unit) : 1.48 Description : DR selling price is the price calculated by the issuer based on the market price of the underlying foreign security, converted using a reference rate and exchange rate, and including the applicable administrative expenses incurred in buying foreign securities. Details of underlying Underlying security type : Units of Foreign Collective Investment Scheme Underlying symbol : 2820 Underlying name : GLOBAL X CHINA BIOTECH ETF (2820) Underlying issuer name : Mirae Asset Global Investments (Hong Kong) Limited Underlying exchange : The Stock Exchange of Hong Kong Limited (HKEX) URL of underlying : https://www.globalxetfs.com.hk/funds/china-bi otech-etf/ Investment summary : The investment objective of Global X China Biotech ETF's (the "Fund") is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China Biotech Index ______________________________________________________________________